# Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions

> **NCT01367652** · PHASE1 · COMPLETED · sponsor: **Roxane Laboratories** · enrollment: 28 (actual)

## Conditions studied

- Breast Cancer

## Interventions

- **DRUG:** Letrozole
- **DRUG:** Letrozole

## Key facts

- **NCT ID:** NCT01367652
- **Lead sponsor:** Roxane Laboratories
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-03
- **Primary completion:** 2008-04
- **Final completion:** 2008-04
- **Target enrollment:** 28 (ACTUAL)
- **Last updated:** 2018-01-23


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01367652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01367652, "Bioequivalency Study of Letrozole 2.5 mg Tablets Under Fasted Conditions". Retrieved via AI Analytics 2026-06-13 from https://api.ai-analytics.org/clinical/NCT01367652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*